
Melanotan 1 (MT-1)
Photosensitivity Relief
$19.99
Out of stock
Melanotan 1 (MT-1) (Research Use Only)
Product Description
Melanotan 1 (MT-1), a synthetic 13-amino-acid peptide, is designed solely for laboratory research to study melanocortin-1 receptor (MC1R) interactions. This peptide, structurally similar to alpha-melanocyte-stimulating hormone (α-MSH), is intended for controlled in vitro experiments and preclinical animal studies investigating melanocortin signaling pathways. It is not approved by the FDA for human or veterinary consumption, diagnostic use, or therapeutic applications. Research Applications
In Vitro Experiments: Suitable for cell culture studies analyzing MC1R activation and its effects on cellular pathways in controlled laboratory settings.
Preclinical Studies: Appropriate for animal-based research exploring melanocortin receptor signaling or related molecular processes under strict experimental conditions.
Biochemical Research: Can be used to investigate peptide-receptor binding, stability, or downstream cellular effects in laboratory environments.
Mechanism of Action (Research Context)
In experimental settings, MT-1 may be studied for:
Interactions with MC1R in in vitro or preclinical models.
Effects on cellular signaling pathways in controlled research environments.
Molecular processes related to melanocortin receptor activity.
Product Specifications
Purity: ≥98% (verified by HPLC, Certificate of Analysis included).
Form: Lyophilized powder for reconstitution in laboratory-grade solvents.
Storage: Store at -20°C in a dry, controlled environment to ensure stability for research use.
Packaging: Supplied in sterile vials for laboratory applications.
Important Notes
Research Use Only: MT-1 is strictly for laboratory research by qualified professionals and is not intended for human or animal consumption, diagnostic, or therapeutic purposes. Non-research use violates federal regulations under Sections 503A/503B of the FD&C Act.
Researcher Verification: Orders require confirmation of affiliation with a research institution, academic laboratory, or biotechnology firm to comply with research-use-only (RUO) restrictions.
Safety: Handle according to established laboratory safety protocols. This product has not been evaluated for human safety or efficacy by the FDA.
Ordering Information
Available exclusively for research institutions, academic laboratories, and biotechnology firms.
Each order includes a Certificate of Analysis from an FDA-registered manufacturer to confirm quality for research purposes.
Disclaimer
Melanotan 1 (MT-1) is provided solely for scientific research and is not FDA-approved for human consumption, medical use, or distribution outside controlled research settings. Any use beyond laboratory research is prohibited and may result in enforcement actions under federal law. Customers must ensure compliance with all applicable regulations, including FDA restrictions on peptide compounding and use. For FDA-approved alternatives, such as afamelanotide for specific medical conditions (e.g., erythropoietic protoporphyria), consult a healthcare professional.
Trusted source for high-quality research peptides.
Support
info@peptidea.net
© 2025. All rights reserved.
Peptidea is a supplier of high-purity peptides, proteins, and amino acid derivatives intended solely for research and development purposes. Our products are not for human consumption. In research settings, peptides are often studied for their potential applications in areas such as weight management, anti-aging, and energy enhancement. All products are provided as lyophilized powders, requiring reconstitution with bacteriostatic water for research use. The statements on this website have not been evaluated by the US Food and Drug Administration, and our products are not intended to diagnose, treat, cure, or prevent any disease. Peptidea is a chemical supplier and is neither a compounding pharmacy nor a chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor an outsourcing facility as defined under Section 503B of the same Act.